Background Direct oral anticoagulants (DOACs) have been developed as alternatives to
conventional therapy with warfarin for the treatment of acute venous thromboembolism (VTE) …

… anticoagulants (NOACs) vs warfarin according to diabetes … patients the strategy of oral
anticoagulation should be tailored to … Results of this meta-analysis support the safety and efficacy …

… oral thrombin inhibitor, and rivaroxaban and apixaban, oral factor Xa inhibitors, have been
found to be safe … We sought to compare the efficacy and safety of the 3 new agents based on …

… Direct oral anticoagulants are contraindicated in patients with … the pharmacology of direct
oral anticoagulants, summarise the … perspectives for the development of oral anticoagulants. …

… To update current knowledge and evaluate the use of DOACs during pregnancy we
systematically reviewed the current literature concerning the efficacy, safety and pregnancy outcome …

… safety and efficacy of oral anticoagulation in older populations with AF, especially in light of
some concerns related to anticoagulant … the type of oral anticoagulant therapy warranting the …

… Direct oral anticoagulants (DOACs) have been shown to be superior to vitamin K … to
safety and efficacy in numerous clinical trials and are now the preferred oral anticoagulant by …

… Despite evolving evidence, the use of direct oral anticoagulants (… compared to warfarin on
safety and efficacy outcomes in extreme … appear safe and effective when compared to warfarin. …

… on the safety and efficacy of direct oral anticoagulants (… The objective of this study is to
describe the safety and efficacy of … primary efficacy outcome of recurrent VTE and primary safety …

… the safety and efficacy profiles of these new oral anticoagulants (NOACs) compared with
LMWHs have been conducted. However, there is limited information on the safety profile of …